China Pharma Holdings, Inc. (NYSE:CPHI – Get Free Report)’s stock price shot up 1% during trading on Wednesday. The stock traded as high as $0.6599 and last traded at $0.6570. 64,322 shares were traded during mid-day trading, a decline of 96% from the average session volume of 1,642,201 shares. The stock had previously closed at $0.6502.
China Pharma Price Performance
The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The firm’s 50-day moving average is $0.94 and its 200-day moving average is $0.85. The company has a market cap of $28.05 million, a PE ratio of -1.52 and a beta of 1.05.
China Pharma Company Profile
China Pharma Holdings, Inc is a pharmaceutical company based in Harbin, Heilongjiang Province, China. Through its operating subsidiaries, the company develops, manufactures and markets pharmaceutical products and nutritional supplements primarily for the Chinese market.
Its product portfolio has included prescription and over-the-counter medicines in dosage forms such as injections, tablets, capsules, granules and oral solutions. The company has also offered products used in areas including antibiotics, cardiovascular care, respiratory treatment, neurology and general health maintenance.
Further Reading
- Five stocks we like better than China Pharma
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
